Posts in Expert Analysis
Research Found an Association Between Muscle Health and NAD+ Abundance in Humans

Aging results in a gradual loss of skeletal muscle function over time. Sarcopenia, the progressive loss of skeletal muscle mass, strength, and performance with age, is one of the critical causes of functional decline in aged adults. Essential for supporting breathing, as well as moving and maintaining posture and balance, skeletal muscle makes up nearly 40% of a young, healthy individual’s total body mass and decreases between 3 to 8% each decade after 30 years of age.

Read More
Combined Metabolic Activators Therapy Reduces Liver Fat by 10% In Nonalcoholic Fatty Liver Disease Patients

A recent phase 2 clinical trial published on Cell Press Sneak Peek, a preprint publication website for papers under review by Cell Press Journals, found that a novel combined metabolic cofactor supplement (CMCS) cocktail which included nicotinamide riboside (NR) significantly reduced hepatic fat in nonalcoholic fatty liver disease (NAFLD) patients by 10%.

Read More
Phase 3 Clinical Trial Demonstrates Combined Metabolic Activators (CMAs) Accelerates Recovery in Mild-to-Moderate COVID-19

Results of a phase 3, double-blind, placebo-controlled trial assessing whether a mixture of Combined Metabolic Activators (CMAs) targeted at mitochondrial function, could improve metabolic function and aid the recovery of mild-to-moderate COVID-19 infected individuals, are now available in the peer-reviewed journal Advanced Science.

The study, conducted at Umraniye Teaching and Research Hospital, University of Health Sciences, Istanbul, Turkey, found that the CMAs, which included nicotinamide riboside (NR), L-serine, N-acetyl-L-cysteine (NAC), and L-carnitine tartrate, when delivered in combination with standard of care, experienced a statistically significant, 3.5 day reduction in recovery time in the COVID-19 infected patients.[1]

Read More
Re-Balancing NAD+ Metabolism Blunts the Impact of Telomere Dysfunction in Human Cells, Mice

A recent study published in The European Molecular Biology Organization Journal, conducted by investigators at the National Institute on Aging (NIA) and the National Cancer Institute (NCI), both divisions of the National Institutes of Health (NIH) has uncovered some important findings related to the relationship between critically short telomere length and telomere dysfunction, the nicotinamide adenine dinucleotide (NAD) metabolome, mitochondrial maintenance, and replicative senescence (a phenomenon where normal cells stop dividing.)

Read More
New Phase 2 Clinical in COVID-19 Patients Finds Hydroxychloroquine (HCQ) Plus Nutritional Protocol Including Nicotinamide Riboside Significantly Improved Recovery Time Vs. HCQ Alone

On the heels of two previously published preclinical studies investigating the effect of viral infection on NAD+ levels, new clinical research in 93 mild-to-moderate COVID-19 infected patients is now available on the open access preprint publication server medRxiv.org.

Read More
Increasing Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Reduced Neurodegeneration, and Increased Lifespan in Preclinical Model

The human body is composed of cells in the trillions. Each cell relies on a resource molecule called NAD+ for the generation of energy we know as ATP. This energy helps cells perform their unique functions and survive. As the available knowledge of NAD+ expands, scientists have come to realize that it also plays a vital role in helping activate important signaling molecules for cellular defense.

Read More